Creon 25000

Creon 25000: description, indications for use and contraindications

Creon 25000 is a drug from the group of enzyme agents designed to improve digestion processes. It contains the active ingredient pancreatin, which is obtained from the pancreas of pigs. Creon 25000 is produced by Solway Pharma in Germany and is a capsule with enteric microgranules of 300 mg.

Indications for the use of Creon 25000 include digestive insufficiency in violation of the exocrine function of the pancreas, such as cystic fibrosis, chronic pancreatitis, pancreatectomy, dyspepsia, Roemheld syndrome, flatulence, impaired digestion of food, intestinal infections, chronic diseases in the liver and biliary tract, intestinal degassing before diagnostic studies.

Contraindications to the use of Creon 25000 include hypersensitivity (including pork intolerance), acute pancreatitis, exacerbation of chronic pancreatitis.

When using Creon 25000, side effects may occur, such as symptoms of intestinal obstruction (formation of strictures in the ileocecal region and ascending colon) and immediate allergic reactions (with cystic fibrosis, especially in children).

In addition, it is worth considering that Creon 25000 may reduce iron absorption, especially with long-term use. Therefore, with long-term use, iron supplements should be prescribed. It is not recommended to exceed the daily dose, especially for patients with cystic fibrosis.

In conclusion, Creon 25000 is an effective drug for the treatment of digestive insufficiency due to impaired exocrine pancreatic function and other diseases. However, before using it, you should familiarize yourself with contraindications and possible side effects, and also consult your doctor.